An Update On The Enfusion Buyout
Clearwater Analytics acquires Enfusion for $1.5 billion, enhancing portfolio management and SaaS revenue growth. Click here ...
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Enfusion, Inc. (ENFN) And Encourages Stockholders to Reach Out
NEW YORK CITY, NY / ACCESS Newswire / January 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger ...
Morningstar23d
Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its Investment Management Platform with Front-to-Back Capabilities
Clearwater Analytics (NYSE: CWAN) (“Clearwater”) and Enfusion, Inc. (NYSE: ENFN) (“Enfusion”) today announced their entry into a definitive merger agreement for Clearwater to acquire ...
Business Insider9d
Enfusion, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESS Newswire / January 27, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Enfusion, ...
TechCrunch22d
Clearwater agrees to buy investment management platform Enfusion for $1.5B
Clearwater, which says it has obtained an $800 million loan to fund the transaction, along with a $200 million revolving line of credit, will let Enfusion’s shareholders elect to receive cash ...
Traders Magazine22d
Clearwater Analytics to Acquire Enfusion for $1.5 Billion
BOISE, Idaho and CHICAGO, Illinois – January 13, 2025 – Clearwater Analytics (NYSE: CWAN) (“Clearwater”) and Enfusion, Inc. (NYSE: ENFN) (“Enfusion”) today announced their entry into a definitive ...
Reuters23d
Clearwater to buy software maker Enfusion for $1.5 bln in expansion push
Jan 13 (Reuters) - Clearwater Analytics (CWAN.N), opens new tab has agreed to acquire Enfusion (ENFN.N), opens new tab in a $1.5 billion cash-and-stock deal as the financial software maker looks ...
Yahoo Finance22d
MS cuts rating on Enfusion stock after Clearwater’s acquisition bid
Investing.com -- Morgan Stanley downgraded Enfusion Inc (NYSE:ENFN) stock to "Equal-weight" from "Overweight" following Clearwater Analytics' proposed $1.5 billion acquisition at $11.25 per share.
Hosted on MSN22d
Clearwater Analytics to buy Enfusion for $11.25 a share
Enfusion management expects preliminary full year 2024 revenue of ~$201M-202M, representing 15-16% year-on-year growth, and preliminary annual recurring revenue as of December 31, 2024, of ~$210M ...
Wall Street Journal5d
Enfusion Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Business Wire23d
Shareholder Alert: Ademi LLP Investigates Whether Enfusion, Inc. Is Obtaining a Fair Price for Its Public Shareholders
MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Enfusion (NYSE: ENFN) for possible breaches of fiduciary duty and other violations of law in its transaction with Clearwater. Click here to ...
Yahoo Finance23d
Clearwater to buy software maker Enfusion for $1.5 billion in expansion push
(Reuters) -Clearwater Analytics has agreed to acquire Enfusion in a $1.5 billion cash-and-stock deal as the financial software maker looks to bolster its international presence and enter the hedge ...